Clinical implications of genetic testing for congenital protein C deficiency in pregnancy
Journal of Obstetrics and Gynaecology Research · 2024
DOI: 10.1111/jog.16138 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Tomoka Maehana und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nara Medical University, Department of obstetrics and gynecology, Kashihara, Nara, Japan. Hauptthemen laut MEDLINE: Protein C Deficiency, Genetic Testing. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Congenital protein C (PC) deficiency is a mostly autosomal dominant hereditary thrombophilia associated with early onset arterial and venous thrombotic diseases. In newborns, PC deficiency results in severe complications such as cerebral hemorrhage, cerebral infarction, and purpura fulminans, leading to death in some cases. We report two cases of deep vein thrombosis diagnosed during pregnancy that prompted genetic testing confirming definitive congenital PC deficiency. One patient with deep vein thrombosis at 30 weeks of gestation underwent anticoagulation therapy with the placement of an inferior vena cava filter. Genetic testing revealed a missense mutation in the PC gene. Another patient developed deep vein thrombosis at 9 weeks of gestation and received anticoagulant therapy, revealing a frameshift mutation in the gene. Genetic testing confirming congenital PC deficiency facilitates tailored postpartum management, including long‐term anticoagulation therapy, based on the mother's thrombosis risk. For newborns, early diagnosis allows timely preparation of treatments, such as freshly thawed frozen plasma or PC replacement therapy and ensures closer monitoring through imaging evaluations, enabling early intervention to decrease the severity of potential complications. Given its utility in managing maternal and neonatal outcomes, early genetic testing in suspected cases of maternal PC deficiency is crucial before delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nara Medical University, Department of obstetrics and gynecology, Kashihara, Nara, Japan.
- Nara Medical University Division of Neonatal Intensive Care, Center of Perinatal Medicine, Nara Medical University Hospital, Kashihara, Nara, Japan.
- Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Hospital, Fukuoka, Japan.
- Department of Gynecology, Cancer Institute Hospital, Koto-ku, Tokyo, Japan.
- Department of Obstetrics and Gynecology, SACRA Ladies Clinic, Kashihara, Nara, Japan.
ORCID-Profile: Tomoka Maehana, Ryuji Kawaguchi, Fuminori Kimura
Zitieren
APA
Maehana, T., Nishikubo, T., Maekawa, R., Hotta, T., Nishikawa, K., Waki, K., Makino, Y., Akasaka, J., Kawaguchi, R., & Kimura, F. (2024). Clinical implications of genetic testing for congenital protein C deficiency in pregnancy. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16138
Vancouver
Maehana T, Nishikubo T, Maekawa R, Hotta T, Nishikawa K, Waki K, et al. Clinical implications of genetic testing for congenital protein C deficiency in pregnancy. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.16138
BibTeX
@article{Maehana2024,
author = {Maehana, Tomoka and Nishikubo, Toshiya and Maekawa, Ryo and Hotta, Taeko and Nishikawa, Kyohei and Waki, Keita and Makino, Yuko and Akasaka, Juria and Kawaguchi, Ryuji and Kimura, Fuminori},
title = {Clinical implications of genetic testing for congenital protein C deficiency in pregnancy},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
doi = {10.1111/jog.16138}
}
EUVIMED